[1]
A. Zedan, R. A. El Fattah, A. Mubarak, and A. Ibrahim, “A Comparative Study on Oral Busulfan and Cyclophosphamide (BU/CY) versus Cyclophosphamide, Melphalan and Vepsid (Etoposide) (CMV) with Autologous Stem Cell Transplant in Patients with Relapsed Non-Hodgkin Lymphomas (NHL)”, rtcms-v4, pp. 30-43, Jul. 2020.